/* CSS to help with ACF styling */ #page-header .h1 {color: #444;} #page-header h2.text-color-xsdn-color {color: #444;}
/* CSS to help with ACF styling */ #page-header .h1 {color: #fff;} #page-header h2.text-color-xsdn-color {color: #fff;}
/* CSS to help with ACF styling */ #page-header .h1 {color: ;} #page-header h2.text-color-xsdn-color {color: ;}
/* CSS to help with ACF styling */ #page-header {background-color: #031ac3;}
/* CSS to help with ACF styling */ #page-header {background: #fff url() center center; padding-top: 0px; padding-bottom: 0px; } @media all and (max-width: 4699px) and (min-width: 1925px) { .title-and-subtitle-background-image { padding-top: 3% !important; padding-bottom: 3% !important; } }
/* CSS to help with ACF styling */ #page-header {background: ;}

FairWarning and Meaningful Use Article

ARRA HITECH of 2009 offers healthcare providers incentives for the adoption of Electronic Health Records (EHRs). In order to qualify for these incentives, providers must achieve progressive stages of meaningful use. FairWarning® has taken a leadership position in collaborating with EHR vendors, systems integrators, customers, and other stakeholders for the advancement of patient privacy. As of January 2013, this document captures all of the privacy and security considerations of meaningful use.







RELATED LEARNING CENTER

  • Increase Visibility Into Your Drug Diversion Monitoring Program
    Learn More
    Data Sheet
    Increase Visibility Into Your Drug Diversion Program
  • Addressing Drug Diversion in Healthcare - Where do I Start?
    Learn More
    Whitepaper
    Addressing Drug Diversion In Healthcare: Where Do I Start?
  • Learn More
    Data Sheet
    GDPR Mapping Guide